University of Medicine Gottingen
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gross, Oliver
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
NCT02378805: European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

Recruiting
N/A
500
Europe
ACE-inhibitor, Ramipril, AT1-inhibitor, HMG-Coenzyme inhibitor (statin), Spironolactone, Paricalcitol, SGLT2 inhibitor
University Hospital Goettingen, Society for Pediatric Nephrology (Germany), Deutsche Gesellschaft für Nephrologie, Alport Selbsthilfe e.V., Association pour l'Information et la Recherche sur les Maladies Rénales Génétiques (AIRG), KfH Foundation Preventive Medicine
Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease, Thin Basement Membrane Disease, Familial Benign Hematuria
07/10
01/35
bTUNED, NCT04315142: Bladder and TranscUtaneous Tibial Nerve Stimulation for NEurogenic Lower Urinary Tract Dysfunction

Recruiting
N/A
240
Europe, RoW
Experimental TTNS, Sham TTNS
University of Zurich
Neurogenic Bladder Dysfunction
08/26
08/26

Download Options